One shot to ease anxiety? new drug RE104 enters human trial

NCT ID NCT07489651

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase 2 trial tests whether a single injection of RE104 can reduce anxiety symptoms in 64 adults with generalized anxiety disorder, compared to a placebo. Participants receive one dose and are followed for four weeks to measure changes in anxiety severity using a standard rating scale. The study is currently recruiting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
RE104 for injection
What this could lead to
If it works, this could point toward a fast-acting, single-dose treatment option for generalized anxiety disorder.
What could go wrong
This is an early Phase 2 trial with only 64 people, so results may not apply broadly. The drug may not reduce anxiety better than placebo, and side effects are still being studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENERALIZED ANXIETY DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Aim Trials, LLC

    RECRUITING

    Plano, Texas, 75093, United States

  • Atlanta Center for Medical Research

    RECRUITING

    Atlanta, Georgia, 30331, United States

  • Austin Clinical Trial Partners

    RECRUITING

    Austin, Texas, 78737, United States

    Contact Email: •••••@•••••

  • BioBehavioral Research Austion

    RECRUITING

    Austin, Texas, 78759, United States

  • Cedar Clinical Research

    RECRUITING

    Draper, Utah, 84020, United States

  • CenExel iResearch, LLC

    RECRUITING

    Decatur, Georgia, 30030, United States

  • Collaborative Neuroscience Research, LLC

    RECRUITING

    Garden Grove, California, 92845, United States

  • Henry Ford Medical Center - Columbus

    RECRUITING

    Novi, Michigan, 48377, United States

  • Inner Space State Street

    RECRUITING

    Orem, Utah, 84058, United States

  • Innovative Clinical Research, Inc.

    RECRUITING

    Lauderhill, Florida, 33319, United States

  • Kadima Neuropsychiatry Institute

    RECRUITING

    La Jolla, California, 92037, United States

  • Lighthouse Psychiatry

    RECRUITING

    Gilbert, Arizona, 85234, United States

    Contact Email: •••••@•••••

  • Midwest Research Group

    RECRUITING

    Saint Charles, Missouri, 63304, United States

  • NYU-H+C Clinical and Translational Science Institute

    RECRUITING

    New York, New York, 10016, United States

  • Neuro-Behavioral Clinical Research, Inc.

    RECRUITING

    North Canton, Ohio, 44720, United States

  • Open Mind Therapeutics

    RECRUITING

    San Francisco, California, 94114, United States

  • Preferred Research Partners, Inc.

    RECRUITING

    Little Rock, Arkansas, 72211, United States

  • Summit Headlands LLC

    RECRUITING

    Portland, Oregon, 97210, United States

  • TRIP Clinic at Psychedelic Science Institute

    RECRUITING

    Santa Monica, California, 90404, United States

    Contact Email: •••••@•••••

  • UNM Research Program Psychedelic Therapies

    RECRUITING

    Albuquerque, New Mexico, 14624, United States

  • University of South Florida

    RECRUITING

    Tampa, Florida, 33613, United States

  • Uptown Research Institute

    RECRUITING

    Chicago, Illinois, 60640, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.